Methylcellulose
It is commonly used as a thickening, stabilizing, and suspending agent, and has been studied for its potential applications in drug delivery, tissue engineering, and other biomedical fields.
Methylcellulose exhibits unique rheological properties, including shear-thinning behavior and thermoreversible gelation, which make it a valuable tool for optimizing and standardizing experimental protocols.
Researchers can leverage PubCompare.ai's AI-driven platform to locate the best published protocols, pre-prints, and patents for their Methylcellulose-based studies, while ensuring reproducibility and accuracy through detailed comparisons.
This cutting-edge tool can help unleash the full potential of Methylcellulose experiments and accelerate scientific discovery.
Most cited protocols related to «Methylcellulose»
The optimal formulation of HES plasma expander and the value of alternatives such as succinylated gelatin and methyl cellulose.
The use of low-speed centrifugation instead of sedimentation to separate LRP from red blood cells.
The added value of an optional additional centrifugation step to reduce the amount of contaminating platelets before labelling.
The use of PBS or saline as an alternative to CFP as the medium for cell labelling and resuspension.
The use of PRP instead of CFP, PBS or saline for centrifugation after labelling.
The use of PBS as an alternative to CFP for reconstitution of labelled WBC.
The need for gradient centrifugation and the availability of GMP grade gradient solutions for granulocyte purification.
Qualification and training required for personnel who perform WBC labelling.
Requirements for equipment and infrastructure for WBC labelling.
Most recents protocols related to «Methylcellulose»
Example 10
Spray-dried disodium FDKP/insulin powder as described in Examples 6 or 7 is packed into hard gelatin capsules. The capsules can contain approximately 50-100 mg of powder. The FDKP salt/insulin powders prepared in Examples 6 and 7 were 25% insulin by weight and insulin activity was about 26 units/mg. Thus, 50 mg would be on the order of 1300 units, significantly larger than a typical dose. About 2-30 mg of the FDKP salt/insulin powder is mixed with methyl cellulose (other bulking agents are well known in the art) to make up the balance of the desired mass.
Example 51
The NOD SCID gamma mouse model of chronic, asymptomatic C. parvum infection was used to test in vivo compound efficacy. NOD SCID gamma mice were infected with ˜1×105 C. parvum oocysts by oral gavage 5-7 days after weaning. The infected animals begin shedding oocysts in the feces 1 week after infection, which is measured by quantitative PCR (qPCR). Based on experience with the positive control compound paromomycin, four mice are required per experimental group to achieve 80% power to detect an 80% percent reduction in parasite shedding after four days of drug compound. In additional to the experimental drug regimen groups, additional negative (gavage with DMSO/methylcellulose carrier) and positive (paromomycin 2000 mg/kg once daily) control groups are included in each experiment. Mice are infected 5-7 days after weaning (day −6), infection is confirmed 1 week later (day 0), and experimental compounds are dosed by oral gavage on days 1-4. The dosing frequency was as indicated. Treatment efficacy was assessed by measurement of fecal oocyst shedding by qPCR on day 5.
Example 16
-
- A composition comprising:
- about 0.01% to 3.0% of a plurality of functionalized metallic nanofibers;
- a first solvent comprising about 2.5% to 28% 1-butanol, ethanol, 1-pentanol, 1-hexanol, acetic acid, 2-propanol (isopropyl alcohol or IPA), 1-methoxy-2-propanol, diethylene glycol, or mixtures thereof;
- a viscosity modifier, resin, or binder comprising about 0.05% to 5.0% cellulose resin such as hydroxy methylcellulose, methylcellulose, ethyl cellulose, propyl methylcellulose, methoxy cellulose, methoxy methylcellulose, methoxy propyl methylcellulose, hydroxy propyl methylcellulose, carboxy methylcellulose, hydroxy ethylcellulose, ethyl hydroxyl ethylcellulose, or mixtures thereof;
- a second solvent comprising about 5% to 50% of n-propanol, 2-propanol, propylene glycol, or diethylene glycol, or mixtures thereof; and
- with the balance comprising a third solvent such as 1-methoxy-2-propanol, cyclohexanol, cyclohexanone, cyclopentanone, cyclopentanol, butyl lactone, or mixtures thereof.
To prepare the chambers, a clean glass coverslip was plasma-treated and fixed to a clean glass slide using strips of double-sided tape to create two parallel chambers of ∼10 µl. The surface was blocked and functionalized by incubating with a mix of 95% PLL-g-PEG and 5% PLL-g-PEG-biotin (0.1 mg/ml in 10 mM Hepes, pH 7.40; SuSoS) for 10 min. After washing with MRB80 supplemented with 40% [vol/vol] glycerol (MRB80-gly40), NeutrAvidin was introduced and incubated for 10 min. After washing, 50-fold diluted GMPCPP seeds were introduced and incubated for 5 min before washing once more and then incubating with Κ-casein for >3 min.
All reaction mixtures (MT mix, expansion mix, rigor mix, washout mix) were prepared at double the volume for the paired compacted/expanded lattice samples and split into two equal parts prior to the addition of DMSO (compacted control) or 20 µM Taxol (expanded). Reagents were added to MRB80-gly40 such that the effective glycerol concentration in the MT mix was 20% and in the other mixes was ∼27%. All mixes contained 0.1% [wt/vol] methylcellulose, 0.5 mg/ml K-casein, 50 mM glucose, 0.2 mg/ml catalase, 0.5 mg/ml glucose oxidase, and 10 mM DTT. The MT mix additionally contained 1 mM GTP, 10.8 µM porcine tubulin (Cytoskeleton), and 0.6 µM TRITC-labeled porcine tubulin (Cytoskeleton). The expansion mix additionally contained 50 mM KCl and 20 µM Taxol (or the equivalent dilution of DMSO). The rigor mix additionally contained 50 mM KCl, 20 µM Taxol (or the equivalent dilution of DMSO), 2 mM ATP, and 15.2 pM StableMARK. The washout mixture additionally contained 50 mM KCl, 20 µM Taxol (or the equivalent dilution of DMSO), and 2 mM ATP. After preparation, these mixtures were spun in an airfuge at 20 psi for 5 min, transferred to clean tubes, and kept on ice until use.
Samples were then moved to the TIRF microscope equipped with a stage-top incubator to maintain them at a constant temperature of 30°C. MTs were grown by flowing in two chamber volumes (ChV) of the MT mix and letting it incubate for 15 min. Subsequently, the chambers were flushed with five ChV MRB80-gly40. Next, the lattices were (mock) expanded by adding two ChV expansion mix (or DMSO equivalent) and incubating for 10 min. Next, two ChV rigor mix was added and incubated for 90 s. Finally, four ChV washout mix was added before imaging. For imaging, the following sequence was used: 2 × Taxol, 4 × DMSO, 4 × Taxol, 4 × DMSO, and either 2 × Taxol or 4 × Taxol and 2 × DMSO (8 or 10 images/condition/assay), and images were taken at similar heights within the channels.
Top products related to «Methylcellulose»
More about "Methylcellulose"
Also known as methyl cellulose, this polymer is commonly utilized as a thickening, stabilizing, and suspending agent.
Its unique rheological properties, including shear-thinning behavior and thermoreversible gelation, make it a valuable tool for optimizing and standardizing experimental protocols.
Methylcellulose has been extensively studied for its potential applications in drug delivery, tissue engineering, and other biomedical fields.
Researchers can leverage PubCompare.ai's AI-driven platform to locate the best published protocols, preprints, and patents for their Methylcellulose-based studies, ensuring reproducibility and accuracy through detailed comparisons.
This cutting-edge tool can help unleash the full potential of Methylcellulose experiments and accelerate scientific discovery.
Closely related terms and products include MethoCult GF M3434, MethoCult M3434, and M3434, which are methylcellulose-based media used for the culture and enumeration of hematopoietic progenitor cells.
Additionally, BFGF (basic fibroblast growth factor) and FBS (fetal bovine serum) are often used in conjunction with Methylcellulose-based systems, while Penicillin/streptomycin is a common antibiotic supplement.
By leveraging this comprehensive knowledge, researchers can optimze their Methylcellulose-based studies and drive innovation in a wide range of fields.